GE HealthCare Technologies Inc. $GEHC Shares Sold by Belpointe Asset Management LLC

Key Points

• Belpointe Asset Management LLC reduced its stake in GE HealthCare Technologies Inc. by 32.6%, holding 17,967 shares worth approximately $1.45 million after selling 8,695 shares in Q1.
• The company's stock experienced a one-year price range between $57.65 and $94.80, with a current valuation around $77.96 and a market cap of $35.59 billion.
• Equities analysts have updated their ratings, with most firms rating GE HealthCare as a "buy", and the average price target set at $88.40.

Belpointe Asset Management LLC decreased its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 32.6% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 17,967 shares of the company's stock after selling 8,695 shares during the quarter. Belpointe Asset Management LLC's holdings in GE HealthCare Technologies were worth $1,450,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. N.E.W. Advisory Services LLC acquired a new position in GE HealthCare Technologies in the 1st quarter worth about $25,000. Bogart Wealth LLC raised its holdings in GE HealthCare Technologies by 260.0% in the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company's stock worth $28,000 after purchasing an additional 247 shares during the period. Stonebridge Financial Group LLC raised its holdings in GE HealthCare Technologies by 165.7% in the 1st quarter. Stonebridge Financial Group LLC now owns 356 shares of the company's stock worth $29,000 after purchasing an additional 222 shares during the period. Ameriflex Group Inc. acquired a new position in GE HealthCare Technologies in the 4th quarter worth about $31,000. Finally, Olde Wealth Management LLC acquired a new position in GE HealthCare Technologies in the 1st quarter worth about $35,000. Institutional investors and hedge funds own 82.06% of the company's stock.

GE HealthCare Technologies Price Performance

NASDAQ:GEHC opened at $77.96 on Friday. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.93 and a current ratio of 1.16. The stock has a market cap of $35.59 billion, a PE ratio of 15.98, a P/E/G ratio of 2.90 and a beta of 1.13. The stock has a 50 day moving average price of $74.45 and a 200 day moving average price of $73.76.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, beating the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The firm had revenue of $5 billion during the quarter, compared to analysts' expectations of $4.96 billion. During the same quarter last year, the firm earned $1.00 earnings per share. The business's revenue for the quarter was up 3.5% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Equities research analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 25th were issued a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend was Friday, July 25th. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 2.87%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the company. Wall Street Zen raised GE HealthCare Technologies from a "hold" rating to a "buy" rating in a report on Saturday, May 31st. Morgan Stanley reduced their target price on GE HealthCare Technologies from $78.00 to $74.00 and set an "equal weight" rating for the company in a report on Thursday, July 31st. BTIG Research reissued a "buy" rating on shares of GE HealthCare Technologies in a report on Monday, July 14th. Citigroup increased their target price on GE HealthCare Technologies from $89.00 to $93.00 and gave the company a "buy" rating in a report on Thursday, July 31st. Finally, Zacks Research raised GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a report on Thursday, August 28th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, GE HealthCare Technologies presently has an average rating of "Moderate Buy" and a consensus price target of $88.40.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.